Sector consensus Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 12/05/2026 am IST			5-day change	1st Jan Change
100.32 ^USD	+1.79%		+3.27%	+1.57%

07/05	Incyte Announces 24-Week Data For Opzelura Cream In Adults With Moderate Atopic Dermatitis	CI
02/05	Incyte Announces Fda Approval of Jakafi Xr Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
INCYTE CORPORATION			108.5	+10.09%	22
REGENERON PHARMACEUTICALS, INC.			875.31	+22.44%	28
UCB			288.21	+23.11%	19
SAMSUNG BIOLOGICS CO.,LTD.			21,80,555.57	+48.14%	25
CSL LIMITED			140.34	+61.67%	16
BIOGEN INC.			217.03	+12.19%	29
MODERNA, INC.			43.37	-20.21%	19
INNOVENT BIOLOGICS, INC.			100.91	+29.07%	27
SWEDISH ORPHAN BIOVITRUM AB			453.69	+4.25%	13
BRIDGEBIO PHARMA, INC.			101.87	+51.16%	23
ALTEOGEN INC.			4,35,000	+27.75%	4
AXSOME THERAPEUTICS, INC.			270.28	+24.33%	21
BIOMARIN PHARMACEUTICAL INC.			90.62	+67.64%	24
KRYSTAL BIOTECH, INC.			318.22	+4.09%	9
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	40.3	-5.82%	1
3SBIO INC.			32.54	+67.81%	11
GRIFOLS, S.A.			14.73	+64.76%	12
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	-	89.17	+24.28%	1
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	-	-	-	-	-
Average			1,45,485.59	+28.71%	17
Weighted average by Cap.			2,65,073.35	+28.44%	21